Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
May 1, 2025
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)
Audrey Larnaudie, Youssef Ghannam, Yasmine El Houat, et al.
The Lancet. Oncology
|
May 11, 2016
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
Christian Carrie, Ali Hasbini, Guy de Laroche, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study
Ewen Anger, Stephane Supiot, Quentin Josset, et al.
Radiation Oncology (London, England)
|
July 5, 2023
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline
Nicolas Martz, Julia Salleron, Frédéric Dhermain, et al.
The Lancet. Oncology
|
October 21, 2019
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
Christian Carrie, Nicolas Magné, Patricia Burban-Provost, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
Celine Bourgier, Didier Cowen, Florence Castan, et al.
JAMA Oncology
|
February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial
Stéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
European Urology
|
June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Sarah Burdett, David J Fisher, Jayne F Tierney, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
May 1, 2025
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)
Audrey Larnaudie, Youssef Ghannam, Yasmine El Houat, et al.
The Lancet. Oncology
|
May 11, 2016
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
Christian Carrie, Ali Hasbini, Guy de Laroche, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study
Ewen Anger, Stephane Supiot, Quentin Josset, et al.
Radiation Oncology (London, England)
|
July 5, 2023
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline
Nicolas Martz, Julia Salleron, Frédéric Dhermain, et al.
The Lancet. Oncology
|
October 21, 2019
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
Christian Carrie, Nicolas Magné, Patricia Burban-Provost, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2021
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
Celine Bourgier, Didier Cowen, Florence Castan, et al.
JAMA Oncology
|
February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial
Stéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
European Urology
|
June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Sarah Burdett, David J Fisher, Jayne F Tierney, et al.
Page
of 8